Loading…

839 Evaluating probiotics usage in a level two local neonatal unit

ObjectivesProbiotic usage in preterm infants is increasing worldwide. A number of randomised controlled trials on probiotics suggest that probiotics reduce rates of necrotising enterocolitis, late onset sepsis, and mortality. The European Society for Paediatric Gastroenterology, Hepatology, and Nutr...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood 2023-07, Vol.108 (Suppl 2), p.A163-A164
Main Authors: Quaynor, Josephine, Abdurrazaq, Abdul, Karupaiah, ASHOK, Worsey, Sue, Tabassum, Shazia
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page A164
container_issue Suppl 2
container_start_page A163
container_title Archives of disease in childhood
container_volume 108
creator Quaynor, Josephine
Abdurrazaq, Abdul
Karupaiah, ASHOK
Worsey, Sue
Tabassum, Shazia
description ObjectivesProbiotic usage in preterm infants is increasing worldwide. A number of randomised controlled trials on probiotics suggest that probiotics reduce rates of necrotising enterocolitis, late onset sepsis, and mortality. The European Society for Paediatric Gastroenterology, Hepatology, and Nutrition has recently made recommendations on probiotic strains that have proven effective and measures to take before commencing probiotics in a neonatal unit. The main objective of this audit was to monitor compliance with the commencement and discontinuation of probiotics against local guidelines in a local neonatal unit.MethodsA retrospective audit was conducted over the 6-month period (February – July 2022). Probiotics (Proprems®) were offered to babies less than 32 weeks, or less than 1.5kgs in weight and on feeds of more than 20ml/kg/day. Administration of probiotics was by nurses. Data was collected viaanonymised survey completed by doctors working in the department.anonymised survey form completed by parents whose babies were commenced on probiotics.evidence of documentation on the commencement and discontinuation of probiotics in either the patient’s paper and/or electronic records (Badgernet).Data received was analysed with Likert scales and generated tables and charts.ResultsA total of 20 babies were started on probiotics over the 6-month period. All the patients (n=20; 100%) were started according to the local guidelines. 80% of the patients (n=16) were discontinued at 34 weeks. A total of 16 doctors responded with 81% (n=13) aware of the usage of probiotics in the unit. Just over half of the doctors (56% n= 9) were aware of when to commence and discontinue probiotics. Only 44% of the doctors (n=7) were conversant with how to prescribe probiotics. Ten responses were received from parents whose babies had been started on probiotics. All the parents (n=10; 100%) felt they easily understood the leaflet given to them prior to the commencement of probiotics. They also felt their concerns about probiotic usage were addressed appropriately.Recommendationsprocuring liquid form of the probiotics and direct addition to bolus feeds.including probiotic prescription writing to doctors’ induction program.encouraging clear documentation of probiotics start and end times.ConclusionThe audit showed good compliance against local guidelines regarding the commencement and discontinuation of probiotics. However, there was limited knowledge of probiotic prescribing among do
doi_str_mv 10.1136/archdischild-2023-rcpch.264
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2829018819</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2829018819</sourcerecordid><originalsourceid>FETCH-proquest_journals_28290188193</originalsourceid><addsrcrecordid>eNqNjEsKwjAYhIMoWB93CHRdzYvyd60VD-BeYhptJCS1SerWjRf1JHbhAVzN8M3HIJRTsqGUl1vZq7YxQbXGNgUjjBe96lS7YaWYoIyKEkYqxBRlhBBeVAAwR4sQ7oRQBsAztAdefV7vepA2yWjcDXe9vxgfjQo4BXnT2DgssdWDtjg-PbZeSYud9k7GsSRn4grNrtIGvf7lEuWH-rQ7FuPXI-kQz3efejdOZwasIhSAVvw_6wtu-UbO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2829018819</pqid></control><display><type>article</type><title>839 Evaluating probiotics usage in a level two local neonatal unit</title><source>Social Science Premium Collection</source><source>Education Collection</source><creator>Quaynor, Josephine ; Abdurrazaq, Abdul ; Karupaiah, ASHOK ; Worsey, Sue ; Tabassum, Shazia</creator><creatorcontrib>Quaynor, Josephine ; Abdurrazaq, Abdul ; Karupaiah, ASHOK ; Worsey, Sue ; Tabassum, Shazia</creatorcontrib><description>ObjectivesProbiotic usage in preterm infants is increasing worldwide. A number of randomised controlled trials on probiotics suggest that probiotics reduce rates of necrotising enterocolitis, late onset sepsis, and mortality. The European Society for Paediatric Gastroenterology, Hepatology, and Nutrition has recently made recommendations on probiotic strains that have proven effective and measures to take before commencing probiotics in a neonatal unit. The main objective of this audit was to monitor compliance with the commencement and discontinuation of probiotics against local guidelines in a local neonatal unit.MethodsA retrospective audit was conducted over the 6-month period (February – July 2022). Probiotics (Proprems®) were offered to babies less than 32 weeks, or less than 1.5kgs in weight and on feeds of more than 20ml/kg/day. Administration of probiotics was by nurses. Data was collected viaanonymised survey completed by doctors working in the department.anonymised survey form completed by parents whose babies were commenced on probiotics.evidence of documentation on the commencement and discontinuation of probiotics in either the patient’s paper and/or electronic records (Badgernet).Data received was analysed with Likert scales and generated tables and charts.ResultsA total of 20 babies were started on probiotics over the 6-month period. All the patients (n=20; 100%) were started according to the local guidelines. 80% of the patients (n=16) were discontinued at 34 weeks. A total of 16 doctors responded with 81% (n=13) aware of the usage of probiotics in the unit. Just over half of the doctors (56% n= 9) were aware of when to commence and discontinue probiotics. Only 44% of the doctors (n=7) were conversant with how to prescribe probiotics. Ten responses were received from parents whose babies had been started on probiotics. All the parents (n=10; 100%) felt they easily understood the leaflet given to them prior to the commencement of probiotics. They also felt their concerns about probiotic usage were addressed appropriately.Recommendationsprocuring liquid form of the probiotics and direct addition to bolus feeds.including probiotic prescription writing to doctors’ induction program.encouraging clear documentation of probiotics start and end times.ConclusionThe audit showed good compliance against local guidelines regarding the commencement and discontinuation of probiotics. However, there was limited knowledge of probiotic prescribing among doctors, so the plan is to include prescription training in the doctor’s induction program.Referencevan den Akker, Chris HP, et al. ‘Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics.’ Journal of Pediatric Gastroenterology and Nutrition, 2020;70(no. 5):664–80, https://doi.org/10.1097/MPG.0000000000002655.</description><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/archdischild-2023-rcpch.264</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Clinical trials ; Documentation ; Enterocolitis ; Gastroenterology ; Guidelines ; Hepatology ; Infants ; Intensive care ; Likert Scales ; Logical Thinking ; Medical personnel ; Necrotizing enterocolitis ; Neonatal care ; Neonates ; Newborn babies ; Nutrition ; Pediatrics ; Physicians ; Premature babies ; Premature Infants ; Probiotics ; Sepsis ; Surveys ; Young Children</subject><ispartof>Archives of disease in childhood, 2023-07, Vol.108 (Suppl 2), p.A163-A164</ispartof><rights>2023 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,33611,33877</link.rule.ids></links><search><creatorcontrib>Quaynor, Josephine</creatorcontrib><creatorcontrib>Abdurrazaq, Abdul</creatorcontrib><creatorcontrib>Karupaiah, ASHOK</creatorcontrib><creatorcontrib>Worsey, Sue</creatorcontrib><creatorcontrib>Tabassum, Shazia</creatorcontrib><title>839 Evaluating probiotics usage in a level two local neonatal unit</title><title>Archives of disease in childhood</title><description>ObjectivesProbiotic usage in preterm infants is increasing worldwide. A number of randomised controlled trials on probiotics suggest that probiotics reduce rates of necrotising enterocolitis, late onset sepsis, and mortality. The European Society for Paediatric Gastroenterology, Hepatology, and Nutrition has recently made recommendations on probiotic strains that have proven effective and measures to take before commencing probiotics in a neonatal unit. The main objective of this audit was to monitor compliance with the commencement and discontinuation of probiotics against local guidelines in a local neonatal unit.MethodsA retrospective audit was conducted over the 6-month period (February – July 2022). Probiotics (Proprems®) were offered to babies less than 32 weeks, or less than 1.5kgs in weight and on feeds of more than 20ml/kg/day. Administration of probiotics was by nurses. Data was collected viaanonymised survey completed by doctors working in the department.anonymised survey form completed by parents whose babies were commenced on probiotics.evidence of documentation on the commencement and discontinuation of probiotics in either the patient’s paper and/or electronic records (Badgernet).Data received was analysed with Likert scales and generated tables and charts.ResultsA total of 20 babies were started on probiotics over the 6-month period. All the patients (n=20; 100%) were started according to the local guidelines. 80% of the patients (n=16) were discontinued at 34 weeks. A total of 16 doctors responded with 81% (n=13) aware of the usage of probiotics in the unit. Just over half of the doctors (56% n= 9) were aware of when to commence and discontinue probiotics. Only 44% of the doctors (n=7) were conversant with how to prescribe probiotics. Ten responses were received from parents whose babies had been started on probiotics. All the parents (n=10; 100%) felt they easily understood the leaflet given to them prior to the commencement of probiotics. They also felt their concerns about probiotic usage were addressed appropriately.Recommendationsprocuring liquid form of the probiotics and direct addition to bolus feeds.including probiotic prescription writing to doctors’ induction program.encouraging clear documentation of probiotics start and end times.ConclusionThe audit showed good compliance against local guidelines regarding the commencement and discontinuation of probiotics. However, there was limited knowledge of probiotic prescribing among doctors, so the plan is to include prescription training in the doctor’s induction program.Referencevan den Akker, Chris HP, et al. ‘Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics.’ Journal of Pediatric Gastroenterology and Nutrition, 2020;70(no. 5):664–80, https://doi.org/10.1097/MPG.0000000000002655.</description><subject>Clinical trials</subject><subject>Documentation</subject><subject>Enterocolitis</subject><subject>Gastroenterology</subject><subject>Guidelines</subject><subject>Hepatology</subject><subject>Infants</subject><subject>Intensive care</subject><subject>Likert Scales</subject><subject>Logical Thinking</subject><subject>Medical personnel</subject><subject>Necrotizing enterocolitis</subject><subject>Neonatal care</subject><subject>Neonates</subject><subject>Newborn babies</subject><subject>Nutrition</subject><subject>Pediatrics</subject><subject>Physicians</subject><subject>Premature babies</subject><subject>Premature Infants</subject><subject>Probiotics</subject><subject>Sepsis</subject><subject>Surveys</subject><subject>Young Children</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqNjEsKwjAYhIMoWB93CHRdzYvyd60VD-BeYhptJCS1SerWjRf1JHbhAVzN8M3HIJRTsqGUl1vZq7YxQbXGNgUjjBe96lS7YaWYoIyKEkYqxBRlhBBeVAAwR4sQ7oRQBsAztAdefV7vepA2yWjcDXe9vxgfjQo4BXnT2DgssdWDtjg-PbZeSYud9k7GsSRn4grNrtIGvf7lEuWH-rQ7FuPXI-kQz3efejdOZwasIhSAVvw_6wtu-UbO</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Quaynor, Josephine</creator><creator>Abdurrazaq, Abdul</creator><creator>Karupaiah, ASHOK</creator><creator>Worsey, Sue</creator><creator>Tabassum, Shazia</creator><general>BMJ Publishing Group LTD</general><scope>K9.</scope></search><sort><creationdate>20230701</creationdate><title>839 Evaluating probiotics usage in a level two local neonatal unit</title><author>Quaynor, Josephine ; Abdurrazaq, Abdul ; Karupaiah, ASHOK ; Worsey, Sue ; Tabassum, Shazia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_28290188193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Clinical trials</topic><topic>Documentation</topic><topic>Enterocolitis</topic><topic>Gastroenterology</topic><topic>Guidelines</topic><topic>Hepatology</topic><topic>Infants</topic><topic>Intensive care</topic><topic>Likert Scales</topic><topic>Logical Thinking</topic><topic>Medical personnel</topic><topic>Necrotizing enterocolitis</topic><topic>Neonatal care</topic><topic>Neonates</topic><topic>Newborn babies</topic><topic>Nutrition</topic><topic>Pediatrics</topic><topic>Physicians</topic><topic>Premature babies</topic><topic>Premature Infants</topic><topic>Probiotics</topic><topic>Sepsis</topic><topic>Surveys</topic><topic>Young Children</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quaynor, Josephine</creatorcontrib><creatorcontrib>Abdurrazaq, Abdul</creatorcontrib><creatorcontrib>Karupaiah, ASHOK</creatorcontrib><creatorcontrib>Worsey, Sue</creatorcontrib><creatorcontrib>Tabassum, Shazia</creatorcontrib><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quaynor, Josephine</au><au>Abdurrazaq, Abdul</au><au>Karupaiah, ASHOK</au><au>Worsey, Sue</au><au>Tabassum, Shazia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>839 Evaluating probiotics usage in a level two local neonatal unit</atitle><jtitle>Archives of disease in childhood</jtitle><date>2023-07-01</date><risdate>2023</risdate><volume>108</volume><issue>Suppl 2</issue><spage>A163</spage><epage>A164</epage><pages>A163-A164</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><abstract>ObjectivesProbiotic usage in preterm infants is increasing worldwide. A number of randomised controlled trials on probiotics suggest that probiotics reduce rates of necrotising enterocolitis, late onset sepsis, and mortality. The European Society for Paediatric Gastroenterology, Hepatology, and Nutrition has recently made recommendations on probiotic strains that have proven effective and measures to take before commencing probiotics in a neonatal unit. The main objective of this audit was to monitor compliance with the commencement and discontinuation of probiotics against local guidelines in a local neonatal unit.MethodsA retrospective audit was conducted over the 6-month period (February – July 2022). Probiotics (Proprems®) were offered to babies less than 32 weeks, or less than 1.5kgs in weight and on feeds of more than 20ml/kg/day. Administration of probiotics was by nurses. Data was collected viaanonymised survey completed by doctors working in the department.anonymised survey form completed by parents whose babies were commenced on probiotics.evidence of documentation on the commencement and discontinuation of probiotics in either the patient’s paper and/or electronic records (Badgernet).Data received was analysed with Likert scales and generated tables and charts.ResultsA total of 20 babies were started on probiotics over the 6-month period. All the patients (n=20; 100%) were started according to the local guidelines. 80% of the patients (n=16) were discontinued at 34 weeks. A total of 16 doctors responded with 81% (n=13) aware of the usage of probiotics in the unit. Just over half of the doctors (56% n= 9) were aware of when to commence and discontinue probiotics. Only 44% of the doctors (n=7) were conversant with how to prescribe probiotics. Ten responses were received from parents whose babies had been started on probiotics. All the parents (n=10; 100%) felt they easily understood the leaflet given to them prior to the commencement of probiotics. They also felt their concerns about probiotic usage were addressed appropriately.Recommendationsprocuring liquid form of the probiotics and direct addition to bolus feeds.including probiotic prescription writing to doctors’ induction program.encouraging clear documentation of probiotics start and end times.ConclusionThe audit showed good compliance against local guidelines regarding the commencement and discontinuation of probiotics. However, there was limited knowledge of probiotic prescribing among doctors, so the plan is to include prescription training in the doctor’s induction program.Referencevan den Akker, Chris HP, et al. ‘Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics.’ Journal of Pediatric Gastroenterology and Nutrition, 2020;70(no. 5):664–80, https://doi.org/10.1097/MPG.0000000000002655.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/archdischild-2023-rcpch.264</doi></addata></record>
fulltext fulltext
identifier ISSN: 0003-9888
ispartof Archives of disease in childhood, 2023-07, Vol.108 (Suppl 2), p.A163-A164
issn 0003-9888
1468-2044
language eng
recordid cdi_proquest_journals_2829018819
source Social Science Premium Collection; Education Collection
subjects Clinical trials
Documentation
Enterocolitis
Gastroenterology
Guidelines
Hepatology
Infants
Intensive care
Likert Scales
Logical Thinking
Medical personnel
Necrotizing enterocolitis
Neonatal care
Neonates
Newborn babies
Nutrition
Pediatrics
Physicians
Premature babies
Premature Infants
Probiotics
Sepsis
Surveys
Young Children
title 839 Evaluating probiotics usage in a level two local neonatal unit
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T12%3A58%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=839%E2%80%85Evaluating%20probiotics%20usage%20in%20a%20level%20two%20local%20neonatal%20unit&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Quaynor,%20Josephine&rft.date=2023-07-01&rft.volume=108&rft.issue=Suppl%202&rft.spage=A163&rft.epage=A164&rft.pages=A163-A164&rft.issn=0003-9888&rft.eissn=1468-2044&rft_id=info:doi/10.1136/archdischild-2023-rcpch.264&rft_dat=%3Cproquest%3E2829018819%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_28290188193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2829018819&rft_id=info:pmid/&rfr_iscdi=true